
BMC Musculoskeletal Disorders, Год журнала: 2025, Номер 26(1)
Опубликована: Апрель 16, 2025
Язык: Английский
BMC Musculoskeletal Disorders, Год журнала: 2025, Номер 26(1)
Опубликована: Апрель 16, 2025
Язык: Английский
Phytomedicine, Год журнала: 2025, Номер 139, С. 156477 - 156477
Опубликована: Фев. 7, 2025
Язык: Английский
Процитировано
1Pharmaceuticals, Год журнала: 2025, Номер 18(4), С. 479 - 479
Опубликована: Март 27, 2025
Background: Longhorn beetles, a widely recognized group of Chinese traditional medicinal insects, are characterized by their notable hemostatic properties. However, the comprehensive understanding potential has been hindered limitations current research methodologies. Methods: This study focuses on species Glenea cantor (Fabricius), which can produce several generations per year, and introduces novel method using microwave carbonization techniques. By employing an in vitro coagulation test, UHPLC-MS, network pharmacology, molecular docking, dynamics simulation, efficacy mechanism action charcoal medicine (GC-CM) were thoroughly studied. Results: In tests showed that GC-CM significantly reduced activated partial thromboplastin time (APTT) prothrombin (PT), indicating its ability to enhance cascade preliminarily confirming (p < 0.01 vs. blank control group). The analysis revealed comprises 453 components, including 137 bioactive components with high human utilization. After predictions via databases such as SwissTargetPrediction deduplication, 215 targets linked specificity identified. These regulate signaling pathways platelet activation, complement cascades, cGMP-PKG. Molecular docking demonstrated strong affinities between key SRC PIK3R1 compounds 2′,6′-dihydroxy 4′-methoxydihydrochalcone, 1-monolinoleoyl-rac-glycerol (binding energy −5 kcal/mol). simulations show good binding capacity core Conclusions: aim this was elucidate material basis GC-CM, offering model for exploring other insect-based resources.
Язык: Английский
Процитировано
0Frontiers in Pharmacology, Год журнала: 2025, Номер 16
Опубликована: Апрель 11, 2025
Metabolic bone disease (MBD), as one of the most severe metabolic disorders, remains a focal point and challenge in medical research. Numerous studies have demonstrated efficacy Traditional Chinese Medicine (TCM) preventing treating MBD. However, inherent complexity TCM metabolites poses significant limitations elucidating their mechanisms action. The advancement omics technologies, including metabolomics, proteomics, transcriptomics, has greatly facilitated research on These approaches enable identification potential biomarkers exploration pathways underlying interventions for Evidence indicates that monomers, single botanical drugs, herbal formulations are effective, safe, well-tolerated MBD prevention treatment. This review summarizes recent applications key findings metabolomics studying It highlights role technologies uncovering relevant under treatment, providing valuable insights clinical references TCM-based strategies managing
Язык: Английский
Процитировано
0International Immunopharmacology, Год журнала: 2025, Номер 155, С. 114630 - 114630
Опубликована: Апрель 14, 2025
Язык: Английский
Процитировано
0BMC Musculoskeletal Disorders, Год журнала: 2025, Номер 26(1)
Опубликована: Апрель 16, 2025
Язык: Английский
Процитировано
0